ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

XENE Xenon Pharmaceuticals Inc

43.19
-0.56 (-1.28%)
May 06 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Xenon Pharmaceuticals Inc XENE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.56 -1.28% 43.19 17:12:54
Open Price Low Price High Price Close Price Previous Close
43.87 42.67 44.3672 43.19 43.75
more quote information »

Recent News

Date Time Source Heading
5/02/202415:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
4/16/202407:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
4/04/202415:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
3/12/202415:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
3/08/202417:47EDGAR2Form 144 - Report of proposed sale of securities
3/08/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202416:27EDGAR2Form 8-K - Current report
3/07/202418:04EDGAR2Form 144 - Report of proposed sale of securities
3/07/202418:03EDGAR2Form 144 - Report of proposed sale of securities
3/05/202415:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
2/29/202415:10EDGAR2Form 8-K - Current report
2/29/202415:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
2/22/202415:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
2/14/202408:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202407:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
1/03/202407:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
1/02/202415:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202315:16GLOBEXenon Pharmaceuticals Announces Closing of $345.0 Million..
12/02/202311:01GLOBEXenon Pharmaceuticals Provides Updates on Neurology Pipeline..
11/30/202315:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/30/202315:15EDGAR2Form 8-K - Current report
11/29/202321:51GLOBEXenon Pharmaceuticals Announces Pricing of Upsized $300.0..
11/29/202316:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/29/202315:03GLOBEXenon Pharmaceuticals Announces Proposed Public Offering
11/27/202306:03EDGAR2Form 8-K - Current report
11/27/202306:00GLOBEXenon Pharmaceuticals Announces Topline Results from Phase 2..
11/09/202315:06EDGAR2Form 8-K - Current report
11/09/202315:03GLOBEXenon Pharmaceuticals Provides Update on Partnered Program..
11/08/202315:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202315:11EDGAR2Form 8-K - Current report
11/08/202315:01GLOBEXenon Pharmaceuticals Reports Third Quarter 2023 Financial..
11/01/202315:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
10/09/202315:15GLOBEXenon Pharmaceuticals Announces Publication of Results from..
10/06/202307:30GLOBEXenon Pharmaceuticals to Present at Jefferies Inaugural..
9/14/202315:01GLOBEXenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
9/12/202315:30GLOBEXenon Pharmaceuticals Announces Upcoming Investor Webinar..
9/04/202307:30GLOBEXenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
8/31/202315:01GLOBEXenon Pharmaceuticals to Present at the Wells Fargo 2023..
8/10/202318:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202318:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/10/202317:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202317:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/09/202315:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202315:16EDGAR2Form 8-K - Current report
8/09/202315:01GLOBEXenon Pharmaceuticals Reports Second Quarter 2023 Financial..
8/08/202315:07EDGAR2Form 8-K - Current report
8/08/202315:01GLOBEXenon Pharmaceuticals Expands Leadership on its Board of..
8/02/202315:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
6/06/202315:35GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 44th..

Your Recent History

Delayed Upgrade Clock